Munkvad S, Gram J, Jespersen J
Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.
Eur Heart J. 1990 Jun;11(6):525-8. doi: 10.1093/oxfordjournals.eurheartj.a059745.
The balance between the coagulation system generating fibrin and its subsequent removal by the fibrinolytic system determines the fate of fibrin deposited in the vascular system. In a prospective study, selected haemostatic variables assessing this balance were determined in plasma samples from 20 consecutive patients admitted with unstable angina pectoris. Over a follow-up period of 6 years, eight patients developed myocardial infarction, whereas 12 patients did not. There was no significant difference between the two groups in the median plasma concentrations of thrombin-antithrombin III complexes reflecting the coagulant activity. The infarction group was characterized by a significantly lower median activity of tissue plasminogen activator in plasma euglobulins (P less than 0.05), a higher median concentration of tissue plasminogen activator antigen in plasma (P less than 0.05) and a tendency to higher plasma levels of antigenic and functional plasminogen activator inhibition. In all patients, the activities of tissue plasminogen activator inhibitor and of tissue plasminogen activator were significantly associated (rs = -0.4811, P less than 0.05). We conclude that a depressed fibrinolytic capacity attributable to a low tissue plasminogen activator activity is of pathogenetic importance for the development of myocardial infarction in patients with unstable angina pectoris.
凝血系统生成纤维蛋白与随后纤维蛋白溶解系统对其清除之间的平衡,决定了沉积在血管系统中的纤维蛋白的命运。在一项前瞻性研究中,对20例因不稳定型心绞痛入院的连续患者的血浆样本,测定了评估这种平衡的选定止血变量。在6年的随访期内,8例患者发生心肌梗死,而12例患者未发生。反映凝血活性的凝血酶 - 抗凝血酶III复合物的血浆中位数浓度在两组之间无显著差异。梗死组的特征是血浆优球蛋白中组织纤溶酶原激活物的中位数活性显著降低(P<0.05),血浆中组织纤溶酶原激活物抗原的中位数浓度较高(P<0.05),并且抗原性和功能性纤溶酶原激活物抑制的血浆水平有升高趋势。在所有患者中,组织纤溶酶原激活物抑制剂和组织纤溶酶原激活物的活性显著相关(rs = -0.4811,P<0.05)。我们得出结论,组织纤溶酶原激活物活性低导致的纤溶能力降低,对于不稳定型心绞痛患者发生心肌梗死具有发病机制上的重要性。